Ernexa Therapeutics (ERNA) Q2 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q2 2025
-0.61
-0.28
0.06
0.39

Details

Expected EPS
N/A
Actual EPS
-0.61
Surprise EPS
-0.61
Surprise Percent
+∞%

Description

Ernexa Therapeutics (ERNA) has reported earnings of -0.61 per share for Q2 2025.

0 Comments

Share your thoughts